Lapatinib in Treating Patients With Advanced or Metastatic Breast Cancer That Overexpresses HER2

NCT00544804 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Metastatic Cancer

Interventions

DRUG: lapatinib ditosylate
GENETIC: gene expression analysis
OTHER: diagnostic laboratory biomarker analysis

Sponsor

University of California, San Francisco

Collaborators

[object Object]